ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

New Announcement For CREG On Radio-Chemotherapy Combines Study New Available

July 28, 1978

Phase II ThermoDox Trial Demonstrates Positive Response

August 29, 2014

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20%

February 2, 1990

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000